Australia-listed Aroa Biosurgery climbs as annual earnings beat guidance

Aroa Biosurgery

26/05/2026 05:15

** Shares of Aroa Biosurgery ARX.AX rise as much as 3.2% to A$0.64, their highest level since May 11

** Stock logs largest intraday pct gain since May 22

** New Zealand-based soft-tissue regeneration products maker logs FY26 normalised EBITDA of NZ$11 million ($6.44 million) vs guidance of NZ$5 million to NZ$8 million

** Co books 54% myriad sales growth in FY26

** More than 608,000 shares change hands, 2.8 times the 30-day average

** Stock down 15.5% YTD, including the day's moves

($1 = 1.7079 New Zealand dollars)

 (Reporting by Nikita Maria Jino in Bengaluru)

 ((Nikita.Jino@thomsonreuters.com;))